Indication

Chlamydia trachomatis urethritis

*Chlamydia trachomatis* urethritis is an infectious inflammation of the urethral mucosa caused by the obligate intracellular bacterium *Chlamydia trachomatis* (typically serovars D through K). Read more about Chlamydia trachomatis urethritis

98 drugs 54 manufacturers

Advertisement

Drugs that treat it

Common Chlamydia trachomatis urethritis therapies.

Showing 91–98 of 98 drugs

AZITHROMYCIN

MACROLIDE ANTIBIOTICS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+27
TARO/SUN PHARMA

AZITHROMYCIN

MACROLIDE ANTIBIOTICS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+27
REMEDYREPACK, I

OFLOXACIN

QUINOLONES·CHLAMYDIA TRACHOMATIS URETHRITIS·+27
MODAVAR PHARMAC

AZITHROMYCIN

MACROLIDE ANTIBIOTICS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+27
AIPING PHARMACE
Filter & compare in the drug finder →Opens the drug finder with Chlamydia trachomatis urethritis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Chlamydia trachomatis urethritis.

*Chlamydia trachomatis* urethritis is an infectious inflammation of the urethral mucosa caused by the obligate intracellular bacterium *Chlamydia trachomatis* (typically serovars D through K).

Primarily transmitted through sexual contact, it affects the genitourinary tract of sexually active adolescents and adults, serving as a leading etiology of nongonococcal urethritis.

Pathophysiologically, bacterial invasion and replication within columnar or transitional epithelial cells trigger local neutrophil recruitment and mucosal inflammation.

Clinically, infection may be asymptomatic or manifest with dysuria, urethral pruritus, and clear, mucoid, or mucopurulent urethral discharge.

Personalize your experience

Follow Chlamydia trachomatis urethritis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it